Bioterrorism and Emerging Infectious Diseases: Antimicrobials, Therapeutics and Immune-Modulators
joint with Rational Design of Vaccines and Immunotherapeutics
Organizer(s): Connie Schmaljohn and Michael BuchmeierDate: January 06 - 11, 2004
Location: Keystone Resort, Keystone, CO, USA
The threats of bioterrorism and emerging infectious diseases have captured the attention of both the scientific and lay communities. Deliberate release of anthrax spores in the U.S. fostered the introduction of homeland security measures worldwide, and led to new efforts to predict the occurrence of and prepare for the appearance of other biothreats. In addition to the use of known pathogens for bioterrorism, there is concern that technological advances in genetic engineering might lead to the creation of novel threat agents for which we are completely unprepared. Not only could such intentionally released pathogens wreak havoc on global health and agricultural systems and economies, so could new naturally occurring disease agents. The recent emergence of SARS and its rapid spread throughout the world is an excellent example of how a novel and unexpected pathogen can quickly overwhelm health care resources. This meeting will address many issues related to preventing and treating diseases caused by exposure to natural or genetically engineered pathogens. Experts in each field will present state-of-the-art research results in plenary talks. Workshops will allow a closer interaction of scientists from many disciplines, who share common goals of understanding and combating biothreats. The Keystone Symposium format offers ample time for discussion and small group meetings and is an ideal means for investigators to gain up to date information on this important topic.
Discounted Abstract Deadline: September 15 2003
Discounted Registration Deadline: November 6 2003